Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management.
Ansell SM.
Am J Hematol. 2024 Dec;99(12):2367-2378. doi: 10.1002/ajh.27470. Epub 2024 Sep 6.
Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management.
Ansell SM.
Am J Hematol. 2022 Nov;97(11):1478-1488. doi: 10.1002/ajh.26717. Epub 2022 Sep 19.
Hodgkin Lymphoma: Diagnosis and Treatment.
Ansell SM.
Mayo Clin Proc. 2015 Nov;90(11):1574-83. doi: 10.1016/j.mayocp.2015.07.005.
Hodgkin lymphoma.
Connors JM, Cozen W, Steidl C, Carbone A, Hoppe RT, Flechtner HH, Bartlett NL.
Nat Rev Dis Primers. 2020 Jul 23;6(1):61. doi: 10.1038/s41572-020-0189-6.
Hodgkin Lymphoma.
Kaseb H, Babiker HM.
2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Syncytial variant of nodular sclerosis Hodgkin lymphoma: an under-emphasized variant.
Wang W, Zhang Q, Medeiros LJ.
Hum Pathol. 2021 Nov;117:115-125. doi: 10.1016/j.humpath.2021.05.008. Epub 2021 May 28.
Primary mediastinal large B-cell lymphoma.
Savage KJ.
Blood. 2022 Sep 1;140(9):955-970. doi: 10.1182/blood.2020008376.
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA.
Am J Surg Pathol. 2003 Oct;27(10):1346-56. doi: 10.1097/00000478-200310000-00007.
Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
Ansell SM.
Am J Hematol. 2020 Aug;95(8):978-989. doi: 10.1002/ajh.25856. Epub 2020 Jun 8.
Nodular sclerosis classical Hodgkin lymphoma grade 2: A diagnostic challenge to the cytopathologists.
Sharma S, Dey P, Mitra S, Rajwanshi A, Nijhawan R, Srinivasan R, Gupta N, Das A.
Cancer Cytopathol. 2017 Feb;125(2):104-113. doi: 10.1002/cncy.21799. Epub 2016 Nov 21.
